[Antitussive agents. 34].
D000111:Acetylcysteine / Q000627:therapeutic use; D000208:Acute Disease; D000470:Alkaloids / Q000627:therapeutic use; D000818:Animals; D000996:Antitussive Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002908:Chronic Disease; D003371:Cough / Q000188:drug therapy; D003408:Cresols / Q000627:therapeutic use; D003864:Depression, Chemical; D004952:Esters / Q000627:therapeutic use; D005100:Expectorants / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D007097:Imines / Q000627:therapeutic use; D008691:Methadone / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D013268:Stimulation, Chemical; D013451:Sulfonic Acids / Q000627:therapeutic use
D000470:Alkaloids; D000996:Antitussive Agents; D000697:Central Nervous System Stimulants; D003408:Cresols; D004952:Esters; D005100:Expectorants; D006993:Hypnotics and Sedatives; D007097:Imines; D010648:Phenylacetates; D000644:Quaternary Ammonium Compounds; D013451:Sulfonic Acids; D008691:Methadone; D000111:Acetylcysteine
Antitussiva. 34.